SCHEMBL2461252

SCHEMBL2461252

c1nc2cc(-c3cn[nH]c3)ccc2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVR1 Q04771 1/20 0.44
PIM1 P11309 1/20 0.43
PIM3 Q86V86 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
ALK Q9UM73 1/20 0.42
ILK Q13418 1/20 0.42
AKT1 P31749 1/20 0.42
AKT2 P31751 1/20 0.42
PIK3CD O00329 1/20 0.40
RIPK2 O43353 2/20 0.40
EGFR P00533 1/20 0.40
KDR P35968 1/20 0.40
TGFBR1 P36897 1/20 0.40
DYRK1A Q13627 1/20 0.40
FFAR1 O14842 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GRK2 P25098 1/20 0.39
GRK1 Q15835 1/20 0.39
FASN P49327 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2457178 0.87 DYRK1A (0.54) ACVR1PIM1PIM3PIM2ILK
SCHEMBL28048502 0.82 ALDH1A1 (0.54) PIM1PIM2PIK3CDRIPK2EGFR
SCHEMBL31514582 0.80 RIPK2 (0.60) RIPK2RIPK3
SCHEMBL13394565 0.77 GSK3B (0.54) ACVR1PIM1PIM3ALKKDR
SCHEMBL2462862 0.75 DYRK1A (0.41) PIK3CDRIPK2EGFRKDRTGFBR1
SCHEMBL3305158 0.75 RIPK2 (0.48) PIM1PIM2PIK3CDRIPK2EGFR
SCHEMBL2462304 0.74 ACVR1 (0.44) ACVR1PIM1PIM3PIM2ALK
SCHEMBL927048 0.74 RIPK2 (0.60) PIK3CDRIPK2EGFRKDRTGFBR1
SCHEMBL29478085 0.74 RIPK2 (0.60) PIK3CDRIPK2EGFRKDRTGFBR1
SCHEMBL6650934 0.73 FFAR1 (0.48) PIK3CDRIPK2EGFRKDRTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET ACVR1 277/4885PIM1 1476/4885PIM3 1709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.